Clinical utility of rosuvastatin and other statins for cardiovascular risk reduction among the elderly

Related Experiment Video

Updated: Jun 3, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Sydney B Long1, Michael J Blaha, Roger S Blumenthal

  • 1Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Baltimore, MD, USA.

Clinical Interventions in Aging
|April 8, 2011
PubMed

Insights

Statins significantly reduce cardiovascular disease (CVD) risk in older adults. The JUPITER trial showed greater absolute CVD risk reduction with rosuvastatin in elderly patients, challenging underutilization concerns.

Area of Science:

  • Gerontology
  • Cardiology
  • Pharmacology

Background:

  • Age is a primary risk factor for cardiovascular disease (CVD).
  • Statins effectively reduce CVD events and mortality, yet are underutilized in the elderly population (treatment-risk paradox).
  • Limited studies and guidelines exist for statin use in older adults, especially for primary prevention.

Purpose of the Study:

  • To review the implications of the JUPITER trial subanalysis regarding statin use in older adults.
  • To discuss the broader role of statins in primary prevention for the elderly population.
  • To address the challenges and considerations for statin therapy in elderly individuals.

Main Methods:

  • Analysis of a large primary prevention statin trial (JUPITER) focusing on participants aged 70 years and older.
  • Subanalysis of cardiovascular disease (CVD) risk reduction in elderly participants versus younger participants.
  • Review of existing literature and guidelines concerning statin use in the elderly.

Main Results:

  • The JUPITER trial included a substantial number of elderly participants (5695 individuals ≥ 70 years).
  • Rosuvastatin demonstrated a greater absolute cardiovascular disease (CVD) risk reduction in elderly participants compared to younger ones.
  • These findings suggest potential benefits of statins in older adults that may outweigh the risks.

Conclusions:

  • The JUPITER subanalysis provides evidence supporting the efficacy of statins in elderly individuals for primary CVD prevention.
  • Addressing the treatment-risk paradox is crucial for optimizing cardiovascular health in the growing elderly population.
  • Further research and updated guidelines are needed to guide statin therapy decisions in older adults.

Keywords:
JUPITERelderlyriskrosuvastatin

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...